Infiltration and lysis of tumour cell aggregates by adherent interleukin-2-activated natural killer cells is distinct from specific cytolysis

Natural Immunity

Volumn 15, Issue 2-3, 1997, Pages 87-97

  Johansson, Bengt R ^a,c   Unger, Martin L ^a   Albertsson, Per ^a   Casselbrant, Anna ^a   Nannmark, Ulf ^a   Hokland, Marianne ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b AARHUS UNIVERSITY   (Denmark)

^c Inst of Anatomy and Cell Biology   (Sweden)

Author keywords

B16 melanoma; Cell culture; Cytotoxicity; Electron microscopy; Fluorescence; Interleukin 2; Killer cells, lymphokine activated; Natural killer cells, adherent; Tumour infiltration

Indexed keywords

INTERLEUKIN 2;

ANIMAL CELL; ARTICLE; CELL INVASION; CYTOLYSIS; CYTOTOXICITY; ELECTRON MICROSCOPY; INTERCELLULAR SPACE; KILLER CELL; LYSIS; MALE; MELANOMA B16; MOUSE; NATURAL KILLER CELL; NONHUMAN; TARGET CELL DESTRUCTION; TUMOR CELL;

ADOPTIVE TRANSFER; ANIMALS; CELL ADHESION; CELL AGGREGATION; CYTOTOXICITY, IMMUNOLOGIC; INTERLEUKIN-2; KILLER CELLS, LYMPHOKINE-ACTIVATED; LYMPHOCYTE ACTIVATION; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; TUMOR CELLS, CULTURED;

EID: 8044257703     PISSN: 10188916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Gunji Y, Vujanovic NL, Hiserodt JC, Herberman RB, Gorelik E: Generation and characterization of purified adherent lymphokine-activated killer cells in mice. J Immunol 1989; 142:1748-1754.
2. Basse PH, Nannmark U, Johansson BR, Herberman RB, Goldfarb RH: Establishment of cell-to-cell contact by adoptively transferred adherent lymphokine-activated killer cells with metastatic murine melanoma cells. J Natl Cancer Inst 1991;83: 944-950.
3. Basse P, Herberman RB, Nannmark U, Johansson BR, Hokland M, Wasserman K, Goldfarb RH: Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases. J Exp Med 1991;174:479-488.
4. Nannmark U, Johansson BR, Bryant JL, Unger ML, Hokland ME, Goldfarb RH, Basse PH: Microvessel origin and distribution in pulmonary metastases of B16 melanoma: Implications for adoptive immunotherapy. Cancer Res 1995;55:4627-4632.
5. Vujanovic NL, Yasumura S, Hirabayashi H, Lin WC, Watkins S, Herberman RB, Whiteside TL: Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues. J Immunol 1995;154: 281-289.
6. Schwarz RE, Vujanovic NL, Hiserodt JC: Enhanced anti-metastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic. Cancer Res 1989;49:1441-1446.
7. Whiteside TL, Herberman RB: Characteristics of human natural killer cells and lymphokine-activated killer cells: Their role in the biology and treatment of human cancer. Immunol Allergy Clin 1990; 10:663-704.
8. Henkart PA: Mechanism of lymphocyte-mediated cytotoxicity. Annu Rev Immunol 1985;3:31-58.
9. Podack ER: Molecular mechanisms of cytolysis by complement and by cytolytic lymphocytes. J Cell Biochem 1986;30:133-170.
10. Hook GR, Greenwood MA, Barba D, Ikejiri B, Chen SN, Oldfield EH, Weber RJ, Muul LM: Morphology of interleukin-2 stimulated peripheral blood mononuclear effector cells killing glioma-derived tumor cells in vitro. J Natl Cancer Inst 1988;80:171-177.
11. Burkhardt JK, Hester S, Lapham CK, Argon Y: The lytic granules of natural killer cells are dual-function organelles combining secretory and pre-lysosomal compartments. J Cell Biol 1990;111:2327-2340.
12. Kang Y-H, Mitchell C, Watson LP, Yaffe L: Immunoultrastructural studies of human NK cells. II. Effector-target cell binding and phagocytosis. Anat Rec 1987;217:290-304.
13. Peters PJ, Geuze HJ, Van der Donk HA, Slot JW, Griffith JM, Stam NJ, Clevers HC, Borst J: Molecules relevant for T cell-target cell interaction are present in cytolytic granules of human T lymphocytes. Eur J Immunol 1989;19:1469-1475.
14. Iwasaki K, Kikuchi H, Miyatake S, Aoki T, Yamasaki T, Oda Y: Infiltrative and cytolytic activities of lymphokine-activated killer cells against a human glioma spheroid model. Cancer Res 1990;50:2429-2436.
15. Frey T, Petty HR, McConnell HM: Electron microscopic study of natural killer cell-tumor cell conjugates. Proc Natl Acad Sci USA 1982;79: 5317-5321.
16. Schmidt RE, Caulfield JP, Michon J, Hein A, Kamada MM, MacDermott RP, Stevens RL, Ritz J: T11/ CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules. J Immunol 1988;140:991-1002.
17. Ginsburg H, Coleman R, Davidson S, Yahav H, Khoury C: Secretion of mucoid material by lymphokine-activated killer cells: Study by light and electron microscopy. J Leukoc Biol 1990;47:393-408.
18. Ginsburg H, Khoury C, Davidson S, Yahav H, Mor R: Secretion of two different flowing masses by lymphokine-activated killer cells. Nat Immun 1993;12:25-34.
19. Wasserman K, Kitson RP, Gabauer MK, Miller CA, Herberman RB, Goldfarb RH: Zymographic analysis of extracellular, released and cell-associated proteases of rat interleukin 2-activated natural killer (A-NK) cells. In Vivo 1994;8:33-41.
20. Goldfarb RH, Wasserman K, Herberman RB, Kitson RP: Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. I. Subcellular localization and functional role. J Immunol 1992;149:2061-2068.
21. Nannmark U, Kitson RP, Johansson BR, Rivett AJ, Goldfarb RH: Immunocytochemical localisation of multicatalytic protease complex (proteasome) during generation of murine IL-2 activated natural killer (A-NK) cells. Eur J Cell Biol 1996; 71:402-408.
22. Jääskeläinen J, Kalliomäki P, Paetau A, Timonen T: Effect of LAK cells against three-dimensional tumor tissue. In vitro study using multi-cellular human glioma spheroids as targets. J Immunol 1989;142: 1036-1045.
23. Jääskeläinen J, Lehtonen E, Heikkilä P, Kalliomäki P, Timonen T: Damage to multicellular human H-2 glioma spheroids incubated with LAK cells: An ultrastructural study. J Natl Cancer Inst 1990;82:497-501.
24. Jääskeläinen J, Mäenpää A, Patarroyo M, Gahmberg CG, Somersalo K, Tarkkanen J, Kallio M, Timonen T: Migration of recombinant IL-2-activated T and natural killer cells in the intercellular space of human H-2 glioma spheroids in vitro. J Immunol 1992;149:260-268.
25. Ochalek T, von Kleist S: Study of the resistance of tumor-cell spheroids to penetration and lysis by activated effector cells. Int J Cancer 1994;57:399-405.
26. Kammerer R, von Kleist S: CEA expression of colorectal adenocarcinomas is correlated with their resistance against LAK-cell lysis. Int J Cancer 1994;57:341-347.
27. Garcia de Palazzo I, Holmes M, Gercel-Taylor C, Weiner LM: Antitumor effects of a bispecific antibody targeting CA19-9 antigen and CD16. Cancer Res 1992;5713-5719.
28. Sacks PG, Taylor DL, Racz T, Vasey T, Oke V, Schantz SP: A multicellular tumour spheroid model of cellular immunity against head and neck cancer. Cancer Immunol Immunother 1990;32:195-200.
29. Hirte HW, Clark DA: Factors determining the ability of cytokine-activated killer cells to lyse human ovarian carcinoma targets. Cell Immunol 1991;136:122-132.
30. Unger ML, Johansson BR, Nannmark U: Migration of IL-2 activated natural killer cells in vitro: Influence of extracellular matrix proteins. APMIS, in press.